The Cigna Group (CI) Revenue — Quarter Ended Mar 31, 2023
Revenue increased in the current quarter compared with both the prior quarter and the same quarter last year. The sequential growth was modest, while the year-over-year gain was more pronounced.
Key takeaway
Quarter ended Mar 31, 2023 · FY2023 Q1
Revenue increased in the current quarter compared with both the prior quarter and the same quarter last year. The sequential growth was modest, while the year-over-year gain was more pronounced.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$46.5B
Revenue reported for this quarter.
Quarter-over-quarter
+1.7%
Change from the immediately preceding quarter.
Year-over-year
+5.7%
Change from the comparable year-ago quarter.
Trailing four quarters
$183B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2022 | $45.5B | +5.4% |
| Sep 30, 2022 | $45.3B | +2.2% |
| Dec 31, 2022 | $45.8B | +0.2% |
| Mar 31, 2023 | $46.5B | +5.7% |
Revenue performance
Total revenues rose from the immediately preceding quarter, driven by higher contributions across pharmacy revenues, premiums, and fees and other revenues.
Quarterly comparison
Compared with the same quarter one year earlier, revenues were higher, reflecting broad-based increases in pharmacy revenues, premiums, and fees and other revenues, partially offset by lower net investment income.
What to watch
Monitor the trajectory of net investment income, which declined both sequentially and year-over year.